
Share on:
ChoiceSpine received FDA clearance to market the Blackhawk Ti 3D-Printed Cervical Spacer with standalone clearance. Blackhawk Ti utilizes preassembled integrated anchor technology with a cam-locking mechanism. Featuring BioBond 3D-Printed Titanium porous structure, Blackhawk Ti is available in two anatomical footprints with significant room for graft material and large lateral windows for enhanced visual confirmation.
Initial FDA clearance for the system was granted in 2021.
The Blackhawk Ti Standalone Cervical Spacer system includes:
- ChoiceSpine’s proprietary 3D-printed BioBond technology
- Preassembled integrated anchor technology
- Large open space for bone graft containment & maximum visualization
- 6° lordotic and convex profile configurations available
- Simultaneous, single-step anchor deployment
- External locking indication for easy confirmation
Source: ChoiceSpine
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
RELATED ARTICLES
FDA 510(k) Recap: First Clearances for Companies in Spine and Trauma
Jun 03 2026 , Julie A. Vetalice
Zimmer Biomet Earns 510(k) for Updated ROSA Shoulder System
May 27 2026 , Julie A. Vetalice
DePuy Synthes to Acquire Radiofrequency Tracking Technology
May 26 2026 , Julie A. Vetalice



